Gain-of-function mutations in the KCNJ2 gene, that encodes KIR2.1 protein underlying IK1, associate with ventricular (short QT syndrome type 3 (SQT3)) and atrial (congenital atrial fibrillation (AF)) phenotypes. This evidence concerns the gene KCNJ2 and short QT syndrome type 3.